In 2009, the FDA issued an alert regarding side effects of metoclopramide, which is a main ingredient in Reglan. A serious side effect of the drug is tardive dyskinesia, which is a very serious disorder. Reglan is used to treat gastrointestinal disorders. Healthcare officials were alerted by the FDA that Reglan would require a black box warning about the risk of long-term or high-dose use on its label. A link has been shown between long-term use of metoclopramide and tardive dyskinesia, which involves involuntary and repetitive body movements. The symptoms may still occur, even if the drug has not been used in a while. There is no known treatment for tardive dyskinesia, and it is usually not reversible. Baxter International makes Reglan.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.